NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Brain Cancer



Data on brain cancer detailed by researchers at Fudan University



May 13th, 2008

According to recent research from Shanghai, People's Republic of China, "Background and objective The widely applied (18)FDG is known for its disadvantage in brain tumour PET imaging because of its high background uptake. C-11-choline can achieve high contrast of brain tumour imaging and was expected to have higher sensitivity and specificity."

"We analysed the misdiagnoses in C-11-choline PET imaging in brain tumours with the aim of improving the accuracy of diagnosis with C-11-choline PET imaging. Patients and methods We selected 10 patients proven to have been misdiagnosed on the basis of histopathological correlation and clinical follow-up among 94 patients (110...


Source: Cancer Weekly (2008-05-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login